We offer several options to help cover the cost of XOLAIR® (omalizumab) for eligible patients who are uninsured, have been denied coverage by their health plans or are worried about drug co-pay costs.
The XOLAIR Co-pay Card Program might be able to help eligible patients with drug co-pay costs associated with their XOLAIR prescription.
If privately or publicly insured patients have difficulty paying for their XOLAIR co-pay, co-insurance or other expenses, XOLAIR Access Solutions can refer them to a co-pay assistance foundation* supporting their disease state.
GATCF was established to help patients with unmet medical needs who are uninsured or rendered uninsured by payer denial and who meet specific financial and medical criteria to receive XOLAIR free of charge.Learn more
|*||Genentech and Novartis Pharmaceuticals Corporation do not influence or control the operations of these co-pay assistance foundations, but XOLAIR Access Solutions can assist patients in navigating the process of seeking co-pay assistance by making an appropriate referral based on a patient’s diagnosis and by assisting with the application process. We cannot guarantee co-pay assistance once a patient has been referred by XOLAIR Access Solutions. The foundations to which we refer patients each have their own criteria for patient eligibility, including financial eligibility.|